Probiotics and Gestational Diabetes: How They May Lower Your Risk During Pregnancy

Impact of HN001 Probiotics on Gestational Diabetes Mellitus

Research Overview

A research team from New Zealand has discovered that supplementation with HN001 probiotics during the 14-16 weeks of pregnancy significantly lowers the risk of gestational diabetes mellitus (GDM) compared to a placebo. GDM is linked to various adverse pregnancy outcomes, including preeclampsia, miscarriage, preterm birth, macrosomia, induction of labor, and cesarean delivery. Additionally, it poses risks for long-term obesity and type 2 diabetes in both the mother and child.

Role of Probiotics in Glucose Metabolism

Probiotics, which are live microorganisms beneficial to health, have been shown to improve glucose metabolism. Previous studies have suggested that early pregnancy supplementation with probiotics may decrease the incidence of GDM.

Study Details

An article published in the British Journal of Nutrition examined the effects of HN001 probiotic supplementation on GDM and related pregnancy outcomes. The study involved 423 pregnant women recruited between 2012 and 2014, all of whom or whose partners had a history of asthma, hay fever, or eczema requiring medication. Participants received either HN001 probiotic supplements or a placebo starting at 14-16 weeks of pregnancy and continued for six months postpartum. A glucose tolerance test was conducted at 24-30 weeks, with GDM diagnosed using both international diagnostic criteria and those specific to New Zealand.

Findings

At the beginning of the study, maternal characteristics showed no significant differences between the two groups. The prevalence of GDM, when diagnosed according to international thresholds, was 40% lower in the probiotics group than in the placebo group, although this difference was not statistically significant. However, when applying the New Zealand definition for GDM, the difference became significant, showing a 68% reduction in prevalence. Notably, among older women (over 35 years), probiotic supplementation was associated with a threefold reduction in GDM prevalence. Moreover, HN001 supplementation provided protective benefits against the recurrence of GDM in women with a history of the condition in previous pregnancies.

Conclusion

In summary, early pregnancy probiotic supplementation may effectively reduce the prevalence of GDM, offering a cost-effective and straightforward intervention to help mitigate adverse pregnancy outcomes.

Author

Written By: Dr. Fanni R. Eros